Company Name:  OncoMed Pharmaceuticals Inc  Ticker Symbol:  OMED  CIK Number:  0001302573  WWW Address:  
CEO:  Dr. John A. Lewicki, PhD  No. of Employees:  0 
Common Issue Type:   Business Description: 

  Industry Information:   [more like this] 

Price  Day Change  Bid  Ask  Open  High  Low  Volume  0.89  0.0499  0.89  0.9  0.9361  1.16  0.92  479903 
Market Cap (mil)  Shares Outstanding (mil)  Beta  EPS  DPS  P/E  Yield  52WksRange 
34.4  38.7  0.00  0.21  0.00  0.0  0.0  3.35  0.55 

KEY FIGURES (Latest Twelve Months  LTM)  Yesterday's Close  0.94  $  PE Ratio  LTM  0.0  
Market Capitalisation  34.4  mil 
Latest Shares Outstanding  38.7  mil 
Earnings pS (EPS)  0.21  $ 
Dividend pS (DPS)  0.00  ¢ 
Dividend Yield  0.0  % 
Dividend Payout Ratio   % 
Revenue per Employee  2,019,136  $ 
Effective Tax Rate  0.0  % 
Float  25.0  mil 
Float as % of Shares Outstanding  0.6  % 
Foreign Sales   mil 
Domestic Sales   mil 
Selling, General & Adm/tive (SG&A) as % of Revenue  0.40  % 
Research & Devlopment (R&D) as % of Revenue  0.80  % 
Gross Profit Margin  0.0  % 
EBITDA Margin  14.6  % 
PreTax Profit Margin  0.0  % 
Assets Turnover  50.7  % 
Return on Assets (ROA)  9.2  % 
Return on Equity (ROE)  0.0  % 
Return on Capital Invested (ROCI)  0.0  % 
Current Ratio  5.0  
Leverage Ratio (Assets/Equity)  1.3  
Interest Cover   
Total Debt/Equity (Gearing Ratio)   
LT Debt/Total Capital  0.0  % 
Working Capital pS  1.32  $ 
Cash pS  0.00  $ 
BookValue pS  1.25  $ 
Tangible BookValue pS  1.25  $ 
Cash Flow pS  1.17  $ 
Free Cash Flow pS  1.18  $ 

KEY FIGURES (LTM): Price info 
Price/Book Ratio  0.75  
Price/Tangible Book Ratio  0.00  
Price/Cash Flow   
Price/Free Cash Flow   
P/E as % of Industry Group  0.0  % 
P/E as % of Sector Segment  0.0  % 
  Balance Sheet (at a glance) in Millions 
   DIVIDEND INFO  Type of Payment   
Dividend Rate  0.00 
Current Dividend Yield  0.0 
5Y Average Dividend Yield  
Payout Ratio  0.0 
5Y Average Payout Ratio  0.0 
 
 
 
 
 
  Share price performance previous 3 years 
   Share price performance intraday 
  

PRICE/VOLUME  High  Low  Close  % Price Chg  % Price Chg vs. Mkt.  Avg. Daily Vol  Total Vol 
1 Week        4.1   1,105,181  
4 Weeks  1.27  0.82  0.95  0.9   826,958  15,712,205 
13 Weeks  1.27  0.70  0.76  24.2   578,365  35,858,644 
26 Weeks  2.59  0.55  2.31  59.3   520,092  63,971,413 
52 Weeks  3.35  0.55  2.92  67.8   304,495  76,123,856 
YTD  1.27  0.65    25.3   558,676  41,900,710 
Moving Average  5Days  10Days  10Weeks  30Weeks  200Days  Beta (60Mnth)  Beta (36Mnth) 
 1.00  1.00  0.91  1.19  1.54  0.00  0.00 


GROWTH RATES  5Year Growh  R² of 5Year Growth  3Year Growth 
Revenue  0.03  0.4  0.20 
Income   0.0  
Dividend   0.0  
Capital Spending   NA  
R&D   NA  
Normalized Inc.   NA  
  CHANGES  YTD vs. Last YTD  Curr Qtr vs. Qtr 1Yr ago  Annual vs. Last Annual 
Revenue %    
Earnings %    
EPS %    
EPS $    


SOLVENCY RATIOS  SHORTTERM SOLVENCY RATIOS (LIQUIDITY) 
Net Working Capital Ratio  78.50 
Current Ratio  5.0 
Quick Ratio (Acid Test)  4.8 
Liquidity Ratio (Cash)  5.30 
Receivables Turnover  25.9 
Average Collection Period  14 
Working Capital/Equity  105.9 
Working Capital pS  1.32 
CashFlow pS  1.17 
Free CashFlow pS  1.18 
FINANCIAL STRUCTURE RATIOS 
Altman's ZScore Ratio  1.05 
Financial Leverage Ratio (Assets/Equity)  0.0 
Debt Ratio  0.0 
Total Debt/Equity (Gearing Ratio)  0.00 
LT Debt/Equity  0.00 
LT Debt/Capital Invested  0.0 
LT Debt/Total Liabilities  0.0 
Interest Cover  0.0 
Interest/Capital Invested  0.00 
  VALUATION RATIOS  MULTIPLES 
PQ Ratio  0.00 
Tobin's Q Ratio  0.56 
Current P/E Ratio  LTM  0.00 
Enterprise Value (EV)/EBITDA  4.72 
Enterprise Value (EV)/Free Cash Flow  0.30 
Dividend Yield  0.0 
Price/Tangible Book Ratio  LTM  0.00 
Price/Book Ratio  LTM  0.75 
Price/Cash Flow Ratio  
Price/Free Cash Flow Ratio  LTM  
Price/Sales Ratio  0.00 
P/E Ratio (1 month ago)  LTM  
P/E Ratio (26 weeks ago)  LTM  
P/E Ratio (52 weeks ago)  LTM  
5Y High P/E Ratio  0.0 
5Y Low P/E Ratio  0.0 
5Y Average P/E Ratio  
Current P/E Ratio as % of 5Y Average P/E  
P/E as % of Industry Group  0.0 
P/E as % of Sector Segment  0.0 
Current 12 Month Normalized P/E Ratio  LTM  0.0 
PER SHARE FIGURES 
LT Debt pS  0.00 
Current Liabilities pS  0.51 
Tangible Book Value pS  LTM  1.25 
Book Value pS  LTM  1.25 
Capital Invested pS  1.25 
Cash pS  LTM  0.00 
Cash Flow pS  LTM  1.17 
Free Cash Flow pS  LTM  1.18 
Earnings pS (EPS)  0.21 
  OPERATING RATIOS  PROFITABILITY RATIOS 
Free Cash Flow Margin  102.47 
Free Cash Flow Margin 5YEAR AVG  198.35 
Net Profit Margin  0.1 
Net Profit Margin  5YEAR AVRG.  2.0 
Equity Productivity  0.92 
Return on Equity (ROE)  0.0 
Return on Equity (ROE)  5YEAR AVRG.  
Capital Invested Productivity  0.92 
Return on Capital Invested (ROCI)  0.0 
Return on Capital Invested (ROCI)  5YEAR AVRG.  
Assets Productivity  0.50 
Return on Assets (ROA)  0.1 
Return on Assets (ROA)  5YEAR AVRG.  0.3 
Gross Profit Margin  0.0 
Gross Profit Margin  5YEAR AVRG.  
EBITDA Margin  LTM  14.6 
EBIT Margin  LTM  18.4 
PreTax Profit Margin  2.0 
PreTax Profit Margin  5YEAR AVRG.  2.0 
Effective Tax Rate  0.0 
Effective Tax Rate  5YEAR AVRG.  0.0 
EFFICIENCY RATIOS 
Cash Conversion Cycle  
Revenue per Employee  2,019,136 
Net Income per Employee  
Average Collection Period  
Receivables Turnover  25.9 
Day's Inventory Turnover Ratio  
Inventory Turnover  0.0 
Inventory/Sales  0.0 
Accounts Payble/Sales  4.02 
Assets/Revenue  2.00 
Net Working Capital Turnover  0.87 
Fixed Assets Turnover  32.88 
Total Assets Turnover  0.5 
Revenue per $ Cash  4.59 
Revenue per $ Plant  71.30 
Revenue per $ Common Equity  0.92 
Revenue per $ Capital Invested  0.92 
Selling, General & Adm/tive (SG&A) as % of Revenue  40.9 
SG&A Expense as % of Revenue  5YEAR AVRG.  1.0 
Research & Devlopment (R&D) as % of Revenue  77.5 
R&D Expense as % of Revenue  5YEAR AVRG.  77.5 

 

 